Coler, 1998 - Google Patents
Identification and characterization of novel antigen genes of Mycobacterium tuberculosisColer, 1998
- Document ID
- 2048311408999032341
- Author
- Coler R
- Publication year
External Links
Snippet
Polypeptide antigens present in the culture filtrate or tuberculin purified protein derivative (PPD) of Mycobacterium tuberculosis were purified and evaluated for their ability to stimulate PBMC from PPD-positive healthy individuals or to induce cell mediated delayed-type …
- 239000000427 antigen 0 title abstract description 72
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1523331B1 (en) | Therapeutic tb vaccine | |
AU2011209399B2 (en) | Modified tuberculosis antigens | |
EP0706571B1 (en) | Tuberculosis vaccine | |
US7037510B2 (en) | Hybrids of M. tuberculosis antigens | |
US6410720B1 (en) | Compounds and methods for treatment and diagnosis of mycobacterial infections | |
AU2008224343B2 (en) | Tuberculosis vaccine and diagnostics based on the Mycobacterium tuberculosis esat-6 gene family | |
EP2315773B1 (en) | Polypeptides, polynucleotides and compositions for use in the treatment of latent tubeculosis | |
EP3281638B1 (en) | Mycobacterial antigen composition | |
Bai et al. | Expression and purification of Mycobacterium tuberculosis ESAT-6 and MPT64 fusion protein and its immunoprophylactic potential in mouse model | |
AU746311B2 (en) | Compositions derived from (mycobacterium vaccae) and methods for their use | |
WO2005061534A2 (en) | Improved tuberculosis vaccines | |
AU766093B2 (en) | Tuberculosis vaccine and diagnostic reagents based on antigens from the mycobacterium tuberculosis cell | |
Coler | Identification and characterization of novel antigen genes of Mycobacterium tuberculosis | |
AU2012202486B2 (en) | Tuberculosis vaccine and diagnostics based on the Mycobacterium tuberculosis esat-6 gene family | |
US6406704B1 (en) | Compounds and methods for treatment and diagnosis of mycobacterial infections | |
EP1787994A1 (en) | TB vaccine and diagnostic based on antigens from M. tuberculosis cell | |
Coler et al. | Vaccines Against Mycobacterium tuberculosis: An Overview from Preclinical Animal Studies to the Clinic | |
Haile | Studies on new tuberculosis vaccine candidates in animal models | |
Kimble | Investigation of iron superoxide dismutase DNA from Mycobacterium bovis BCG as a vaccine against mycobacterial infection in mice | |
BROWN et al. | Patent 2731547 Summary | |
BROWN et al. | Patent 2731549 Summary |